ALS drug's approval draws cheers from patients, questions from skeptics -

last year
The Food and Drug Administration has approved a controversial new drug for the fatal condition known as ALS, or Lou Gehrig's disease. The decision is being hailed by patients and their advocates, but questioned by some scientists.